Pediculosis capitis is a prevalent and highly communicable condition infesting millions of elementary school students annually. Topical insecticides are the present standard treatment for this condition. Because resistance of head lice to insecticides is a growing concern, assessment of efficacy of pediculicidal and ovicidal activity of the various agents is needed for public health interests. Given the number of anecdotal and market-driven reported studies, assessment of topical lice therapies requires standardized testing. Evaluations based on adaptations of World Health Organization guidelines are not ideal, whereas a protocol reflecting clinical exposure to insecticides is preferable.
You have requested a machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Neither BioOne nor the owners and publishers of the content make, and they explicitly disclaim, any express or implied representations or warranties of any kind, including, without limitation, representations and warranties as to the functionality of the translation feature or the accuracy or completeness of the translations.
Translations are not retained in our system. Your use of this feature and the translations is subject to all use restrictions contained in the Terms and Conditions of Use of the BioOne website.
Vol. 38 • No. 2